Exelixis News | finanzen.ch

Kurse + Charts + Realtime		News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Strukturierte Produkte

Aktion

Portfolio

Watchlist

02.12.14	FDA Lifts Hold On FLXN Study, All's Well With CPXX Trial, COMET Woes For EXEL (RTTNews)
01.12.14	Exelixis: COMET-2 Trial Of Cabozantinib Fails To Meet Primary Endpoint (RTTNews)
29.09.14	Exelixis Reports Positive Results From Phase 3 Trial Of Cobimetinib (RTTNews)
02.09.14	MÄRKTE USA/Wall Street dürfte nach langem Wochenende leicht zulegen (Dow Jones)
26.03.14	ACT Gets It Right, CPRX On The Move, HALO Shines, Keep Watch On GALT, INSM (RTTNews)
25.03.14	Exelixis Gets Approval For Cometriq In European Union For Treatment Of MTC (RTTNews)
20.02.14	Exelixis Q4 Loss Widens - Quick Facts (RTTNews)
23.01.14	Exelixis Prices $80 Mln Overnight Stock Offering (RTTNews)
25.09.13	Drug Approvals, Data Presentations, Conferences, Increased Funding, and Merger Agreements - Research Report on Theravance, Arena, Exelixis, Verenium, and Enanta (PR Newswire)
11.09.13	FOLD Cuts A Deal, SNTA On Watch, NanoString Makes Mega Leap, GALT Vaults (RTTNews)
10.09.13	Exelixis Begins Phase 3 Trial Of Cabozantinib In Patients With Advanced HCC (RTTNews)
12.08.13	Public Offerings of Common Stock, Financial Results, and Significant Progress in Key Development Programs - Research Report on BioCryst, Exelixis, Idenix, Puma Biotechnology, and Halozyme (PR Newswire)
06.08.13	Exelixis Q2 Loss Widens (RTTNews)
25.07.13	Results Schedules, Management Changes, and Pending NDA Approvals - Research Report on Questcor, VIVUS, Exelixis, Incyte, and Chelsea Therapeutics (PR Newswire)
16.03.10	Exelixis Announces March 24 Webcast of Presentation at the Barclays Capital Global Healthcare Conference (Businesswire)
04.02.10	Exelixis Announces February 9 Webcast of Presentation at the 12th Annual BioCEO and Investor Conference (Businesswire)
13.11.09	Exelixis Announces November 18 Webcast of Presentation at Lazard’s 6th Annual Healthcare Conference (Businesswire)
04.09.09	Exelixis Announces Webcasts of Three Presentations at Healthcare and Biotechnology Conferences in September 2009 (Businesswire)
01.06.09	Exelixis Reports Encouraging Phase 1 Data To Be Presented at ASCO for XL765, a Dual Inhibitor of PI3K and mTOR (Businesswire)
05.02.09	Exelixis Announces February 10 Webcast of Presentation at the 11th Annual BIO CEO & Investor Conference (Businesswire)
23.10.08	Exelixis Retains Rights to Develop and Commercialize XL184 (Businesswire)
23.10.08	Exelixis Reports Positive Phase 1 Data for XL228 at EORTC-NCI-AACR Symposium (Businesswire)
22.10.08	Exelixis Reports Positive Phase 1 Data for PI3K Inhibitor XL147 at EORTC-NCI-AACR Symposium (Businesswire)
28.08.08	CORRECTING and REPLACING Exelixis Announces September 4 Webcast of Presentation at BioCentury's NewsMakers in the Biotech Industry Conference (Businesswire)

Newssuche

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Givaudan	4’040.00	1.71 %	K V
Geberit	547.80	1.59 %	K V
Part Grp Hldg	1’297.00	1.49 %	K V
ABB	51.94	1.29 %	K V
Swiss Life Hldg	691.80	1.26 %	K V
Zurich Insur Gr	548.00	-0.18 %	K V
Kuehne+Nagel Int	210.90	-0.33 %	K V
Swiss Re	128.20	-0.66 %	K V
Sonova Hldg	293.00	-0.85 %	K V
Novartis	87.94	-0.92 %	K V

mehr

30.10.24		Anleger in New York halten sich zurück: NASDAQ Composite gibt zum Handelsende nach
30.10.24		Handel in New York: NASDAQ Composite verbucht Verluste
30.10.24		Gute Stimmung in New York: NASDAQ Composite mittags fester
30.10.24		Mittwochshandel in New York: NASDAQ Composite beginnt Mittwochssitzung in der Gewinnzone
15.10.24		Schwacher Handel in New York: NASDAQ Composite legt schlussendlich den Rückwärtsgang ein
15.10.24		Schwacher Handel: NASDAQ Composite zeigt sich leichter
15.10.24		Dienstagshandel in New York: NASDAQ Composite gibt nach
18.09.24		Angespannte Stimmung in New York: NASDAQ Composite präsentiert sich mittags schwächer